tocophersolan has been researched along with ascorbic acid in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Damian, F; Fabian, J; Friend, DR; Kiser, PF | 1 |
| Che, D; Jin, X; Pei, B; Tong, D; Xia, X; Yuan, G; Zhang, Y | 1 |
2 other study(ies) available for tocophersolan and ascorbic acid
| Article | Year |
|---|---|
Approaches to improve the stability of the antiviral agent UC781 in aqueous solutions.
Topics: 2-Hydroxypropyl-beta-cyclodextrin; Anilides; Antioxidants; Antiviral Agents; Ascorbic Acid; beta-Cyclodextrins; Chemistry, Pharmaceutical; Dimethyl Sulfoxide; Drug Compounding; Drug Stability; Edetic Acid; Excipients; Fumarates; Furans; Glutathione; Hot Temperature; Models, Chemical; Oxidation-Reduction; Polyethylene Glycols; Polysorbates; Solubility; Sulfites; Technology, Pharmaceutical; Thioamides; Time Factors; Vitamin E | 2010 |
Ascorbyl palmitate/d-α-tocopheryl polyethylene glycol 1000 succinate monoester mixed micelles for prolonged circulation and targeted delivery of compound K for antilung cancer therapy in vitro and in vivo.
Topics: A549 Cells; Animals; Apoptosis; Ascorbic Acid; Cell Cycle; Cell Movement; Drug Delivery Systems; Endocytosis; Ginsenosides; Humans; In Situ Nick-End Labeling; Lung Neoplasms; Mice, Nude; Micelles; Succinates; Tumor Burden; Vitamin E | 2017 |